Theracryf Plc (AIM:TCF)
0.1705
-0.0045 (-2.57%)
Oct 16, 2026, 4:29 PM GMT
Theracryf Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.47 | 2.11 | 2 | 5 | 4.51 |
Short-Term Investments | 1.07 | 2.01 | - | - | 4.52 |
Cash & Short-Term Investments | 1.54 | 4.11 | 2 | 5 | 9.03 |
Cash Growth | -62.49% | 105.29% | -59.92% | -44.63% | -22.11% |
Accounts Receivable | 0.38 | 0.39 | 0.4 | - | - |
Other Receivables | 0.27 | 0.63 | 0.58 | 1.02 | 0.48 |
Receivables | 0.65 | 1.01 | 0.97 | 1.02 | 0.48 |
Prepaid Expenses | 0.1 | 0.04 | 0.05 | 0.11 | 0.07 |
Total Current Assets | 2.29 | 5.17 | 3.03 | 6.13 | 9.58 |
Property, Plant & Equipment | 0.01 | - | - | 0 | 0.01 |
Other Intangible Assets | 2.51 | 2.46 | 0.03 | 0.04 | 0.05 |
Total Assets | 4.81 | 7.63 | 3.06 | 6.17 | 9.64 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.28 | 0.11 | 0.33 | 0.4 | 0.07 |
Accrued Expenses | 0.32 | 0.13 | 0.32 | 0.39 | 0.32 |
Current Portion of Leases | 0.01 | - | - | - | - |
Current Income Taxes Payable | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 |
Other Current Liabilities | 1.06 | 1.01 | 0.05 | 0.01 | 0 |
Total Current Liabilities | 1.69 | 1.26 | 0.72 | 0.83 | 0.41 |
Long-Term Deferred Tax Liabilities | 0.41 | 0.4 | - | - | - |
Other Long-Term Liabilities | - | -0 | -0 | - | - |
Total Liabilities | 2.1 | 1.66 | 0.72 | 0.83 | 0.41 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 5.37 | 5.32 | 0.69 | 0.69 | 0.69 |
Additional Paid-In Capital | 28.35 | 28.7 | 27.87 | 27.87 | 27.87 |
Retained Earnings | -33.77 | -30.43 | -28.92 | -25.79 | -21.89 |
Comprehensive Income & Other | 2.76 | 2.38 | 2.7 | 2.58 | 2.56 |
Shareholders' Equity | 2.72 | 5.97 | 2.34 | 5.34 | 9.23 |
Total Liabilities & Equity | 4.81 | 7.63 | 3.06 | 6.17 | 9.64 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 0.01 | - | - | - | - |
Net Cash (Debt) | 1.53 | 4.11 | 2 | 5 | 9.03 |
Net Cash Growth | -62.76% | 105.29% | -59.92% | -44.63% | -22.11% |
Net Cash Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
Filing Date Shares Outstanding | 2,149 | 2,130 | 274.89 | 274.89 | 274.89 |
Total Common Shares Outstanding | 2,149 | 2,130 | 274.89 | 274.89 | 274.89 |
Working Capital | 0.6 | 3.91 | 2.31 | 5.3 | 9.17 |
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 |
Tangible Book Value | 0.2 | 3.51 | 2.31 | 5.3 | 9.17 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 |
Machinery | - | - | - | 0.01 | 0.01 |